LTX-Credence (LTXC) warns Advantest's (ATE) sudden bid to buy Verigy (VRGY) would face...

|By:, SA News Editor

LTX-Credence (LTXC) warns Advantest's (ATE) sudden bid to buy Verigy (VRGY) would face 'extensive' regulatory reviews given existing customer and product overlap. LTX's own proposed buyout would close much sooner, and it plans to protect its rights under that deal. LTX is -11% to $7.52.